Structural Heart Disease Program
VIDEO – Learn about Inova's structural heart program: our doctors, nurses, care coordinators and expert treatment options. Treatment for heart valve disease in Northern Virginia
The Structural Heart Disease team at Inova is dedicated to improving survival and quality of life for people with disease that affects the internal functions of the heart – meaning the valves or walls separating the chambers of the heart.
Request an appointment or refer a patient
To consult a Structural Heart Disease Program physician, call 703-776-3135 or email us.
Have you been told you have any of these heart issues?
valvular heart disease
atrial septal defect
"hole in the heart"
valve or septum issues
Historically, these are issues that have been managed through open heart surgery. More recently, minimally invasive transcatheter therapies have revolutionized care for heart patients, offering better outcomes, shorter length of stay and a more rapid recovery. Our comprehensive approach identifies the best treatment options to suit each patient.
Why go to Inova for your valve treatment?
Inova is a national leader in minimally invasive repair techniques for several reasons.
Read more: Why should I get my valve repaired at Inova? We specialize in minimally invasive heart valve repair and replacement, and stroke risk reduction for AFib
Transcatheter Aortic Valve Replacement (TAVR)
TAVR has revolutionized the treatment of aortic stenosis, offering a minimally invasive alternative to traditional open aortic valve replacement surgery. The transcatheter approach allows for early ambulation, much shorter length of stay, and rapid recovery. Inova offers options for customizable heart valves including the Evolut PRO valve and Sapien 3 valve.
TAVR treatment options are available across all risk profiles including patients with asymptomatic aortic stenosis.
Read more information about TAVR
™ Left Atrial Appendage Closure Device
This procedure is indicated for stroke risk reduction in non-valvular atrial fibrillation (AFib) patients who are not candidates for chronic anticoagulation due to noncompliance, occupational restrictions, long-term bleeding or a strong preference not to take anticoagulants. After placement of the device, which is done in the cath lab followed by an overnight stay, patients can be discharged home with anticoagulation medications permanently discontinued after 45 days.
Learn more about WATCHMAN and meet the doctors who perform this procedure
Transcatheter Mitral Valve Therapies
The MitraClip procedure is indicated for people with significant symptomatic degenerative mitral regurgitation (MR>3+) who are not candidates for surgical mitral valve replacement due to prohibitive risk. The device is placed using a minimally invasive catheter-based approach and real-time imaging and patients generally are discharged home within three days.
Inova is the only hospital in the Washington DC area to offer the Intrepid™ TMVR system through the Apollo trial. This study will offer transcatheter mitral valve replacement to patients who are either ineligible or at increased risk for conventional mitral valve surgery.
Why choose Inova for structural heart treatment in Northern Virginia and Washington, DC metro region
National leader in minimally invasive repair techniques, including transcatheter aortic valve replacement (TAVR) procedures.
Outcomes exceed national average.
Only DC-area hospital participating in the Apollo TMVR trial.
Participant in the PARTNER 3 clinical trial for TAVR procedures in low risk patients.
State-of-the-art hybrid operating room where cardiac surgeons, cardiologists and electrophysiologists operate together for fewer complications and shorter recovery.
Expedited referral-to-OR process.
Easily accessible, just 10 miles from downtown Washington, D.C.
Contact the Inova Structural Heart Program
VIDEO – Meet a satisfied patient: Col Arnald Gabriel had severe aortic stenosis, but is now going stronger than ever after a TAVR procedure at Inova. Top of page